Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

PRA Health Sciences Inc (PRAH) USD0.01

Sell:$105.38 Buy:$105.52 Change: $1.38 (1.29%)
NASDAQ:0.24%
Market closed |  Prices as at close on 21 November 2019 | Switch to live prices |
Sell:$105.38
Buy:$105.52
Change: $1.38 (1.29%)
Market closed |  Prices as at close on 21 November 2019 | Switch to live prices |
Sell:$105.38
Buy:$105.52
Change: $1.38 (1.29%)
Market closed |  Prices as at close on 21 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.

Contact details

Address:
4130 Parklake Ave Ste 400
RALEIGH
27612-4462
United States
Telephone:
+1 (919) 7868200
Website:
www.prahs.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PRAH
ISIN:
US69354M1080
Market cap:
$6.76 billion
Shares in issue:
63.24 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Colin Shannon
    Chairman of the Board, President, Chief Executive Officer
  • Michael Bonello
    Chief Financial Officer, Executive Vice President

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.